Pharma Tech Outlook: Pharma Tech Magazine

 Creative Biolabs: Excellence In Custom Biotechnology And Pharmaceutical Services

Top 10 Drug Discovery Solution Companies - 2021


Unquestionably, the COVID-19 pandemic is one of the biggest challenges the pharma sector has ever encountered. However, it could not put a damper on such an innovative industry. By bringing out the best efforts for vaccine development, the sector has proven its competence in handling any difficulties thrown at them.

On that front, AI is one such technology that has become pivotal for drug discovery, design, and target identification. The technology is increasingly being leveraged for analyzing patterns in data sets to attain insights on implications, benefits, and success rates of new drugs before their launch to the market.

On the other hand, bioprinting is another technology that has been significantly helping in running successful clinical trials. Bioprinting is the technique where imitations of human tissues and organs are created using 3D printing technology. These organs are then replaced for humans during clinical trials in order to understand how humans would react to a particular drug. Bioprinting, as a result, helps to test the drug’s toxicity and its metabolic effects without risking human subjects.

When all things are considered, there is no doubt that the drug development and discovery sector is on the fast track of evolution. Standing at the cusp of emerging technologies, there are a wide range of drug discovery and development solution providers that are offering the latest technologies best suited for the next generation of pharma tech needs. In order to assist the pharma and the healthcare community in the task of finding accomplished drug discovery and development solution providers, we have compiled this issue of Pharma Tech Outlook. In this edition, we have listed the top 10 drug discovery and development solution providers to highlight the organizations that can escalate your growth. This edition also blends through thought leadership from subject matter experts, CIOs, and CXOs. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organization need to foster an ecosystem driven by robust and efficient technology.

We present to you Pharma Tech Outlook’s, “Top 10 Drug Discovery and Development Solution Providers – 2021.”

    Drug Discovery Solutions Companies

  • Biosensing Instrument is a life science company that designs and supplies award winning label-free molecular interaction instruments based on the Surface Plasmon Resonance technology. The company's clients are in the early drug discovery pharma and academic research who are characterizing biophysical properties of small molecules, peptides, antibodies, viruses and bacteria.

  • Certara is currently helping pharma companies unleash the complete benefit of MIDD and reduce cycle times, lower costs, and improve outcomes for cancer patients throughout the entire biopharma R&D process. Certara’s Phoenix™ PK/PD (pharmacokinetic and pharmacodynamics) platform is the crown jewel of the company’s solution stack. The Phoenix platform can easily automate repetitive analytical processes and is widely considered the industry standard for noncompartmental PK analysis (NCA), toxicokinetics (TK), and PK/PD modeling. Alongside this, the Phoenix platform also includes tools for creating turnkey visualizations and submission-ready reporting. Pharma companies can, therefore, use the platform to get fast and easy software validation for MIDD in less than 30 minutes.

  • With an unrelenting drive in bio-scientific research and industry, Creative Biolabs is executing its strategy to bring comprehensive services and products. At its core, Creative Biolabs provides professional custom service packages to fully meet client's specific needs in drug development journey, especially for various antibody related modalities (monoclonal antibody, single domain antibody, bispecific antibody, multi-specific antibody, ADC, CAR T, etc.). In addition to positioning itself as a CRO company, it also treats itself as an extended lab for clients. The company is dedicated to helping scientists to do their research at a faster speed and in a more cost-effective way.

  • AlivaMab Discovery Services

    AlivaMab Discovery Services

    AlivaMab Discovery Services is a leader in the discovery of antibody therapeutics, trusted by top-tier pharmaceutical and biotechnology companies to deliver panels of drug-quality human antibodies. The company meet its partners' design goals, from simple to extraordinarily challenging, through rapid generation of large, molecularly diverse panels of antibodies with deep functional and kinetic characterization, developability assessment and state of the art engineering approaches. Combining collaborative access to its scientists' creativity and experience with the use of trusted, proven technologies, AlivaMab Discovery Services provides the fastest and most de-risked path through discovery and development.

  • BennuBio


    BennuBio is an emerging technology company delivering unique cell analysis systems accommodating large multi-cellular spheroids and single cell analyses at 10 – 100x flow volume and event rates. The company's Velocyt enables near total analyzed sample recovery for further re-analysis, dynamic cellular kinetic studies or repurpose to other workflows. The company is also creating viable cell preserving, rapid enrichment technologies to purify specific cells for in vitro expansion to enable advanced immuno-oncology treatment or selectively isolate and further characterize specific circulating cells and disease states to develop higher precision diagnostics, guidance therapeutics and prediction of minimum residual disease.

  • Cambrex


    Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. With over 40 years’ experience and a growing team of over 2,100 experts servicing global clients from sites in North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and dosage form development and manufacturing.

  • Eurofins DiscoverX

    Eurofins DiscoverX

    Eurofins DiscoverX, the products company of Eurofins Discovery, is committed to enabling and accelerating multi-modality drug discovery and development from discovery to QC lot release. For drug discovery and development scientists, Eurofins DiscoverX is the trusted product solutions provider that accelerates research and drug discovery programs with confidence for cytokine receptors, checkpoint receptors, GPCRs, kinases, ion channels, epigenetics, nuclear receptors, and other target families. Eurofins DiscoverX develops and manufactures cutting edge assays, stable cell lines, ready-to-use kits (including bioassays), membrane preps, enzymes, and reagents for small molecule and biologic immuno-oncology, cytotoxicity, compound-target engagement, potency and QC lot release, pharmacotrafficking, and many other applications.

  • Genesis Biotechnology Group

    Genesis Biotechnology Group

    The Genesis Biotechnology Group is a consortium of vertically integrated corporate entities, which facilitate the overall market implementation and delivery of basic science products such as diagnostic assays and drug discovery. Through the consolidation of research activities in the fields of biotechnology, molecular biology, genome research, biochemistry, nano and biophysics, bioinformatics, and computer science, we are able to cultivate research partnerships between highly productive research teams that break through the barriers of traditional disciplinary boundaries.

  • IHMA


    IHMA provides a full suite of technical capabilities and domain expertise in all phases of antimicrobial drug development: drug discovery, clinical development, regulatory approval and commercialization. IHMA is a premier provider of antimicrobial drug development studies. With laboratories in both the US and Europe, the company partners with clients around the world in the biotechnology, pharmaceutical, and diagnostic industries. IHMA is a leading, independent laboratory specializing in surveillance studies and clinical trials, key milestones along the continuum from drug development to commercialization. It utilizes state of the art technology, leading to first-class testing and data as well as sound economic frameworks.

  • Merck


    Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through its prescription medicines, vaccines, biologic therapies and animal health products, the company worsk with customers and operates in more than 140 countries to deliver innovative health solutions. It also demonstrates its commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.